Patients who had positive ctDNA tests after surgery were almost twice as likely to be alive at 3 years if they received ...

The treatment of stage II colon cancer is a controversial issue that has persisted for the past decade. Clinicians must understand that accurate assessment of risk factors is the key to ...

Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...

An experimental blood test can effectively and accurately detect colon cancer in middle-aged folks and seniors, a new study ...

Aspirin use in patients with PI3K-mutated colorectal cancer helped to reduce disease recurrence, highlighting the importance ...

More frequent follow-up after curative surgery did not significantly reduce 10-year mortality rates in patients with stage II ...

Barry Stein had ignored symptoms that started appearing in 1995, until he was diagnosed with stage four colorectal cancer.

Although ctDNA positivity generally meant worse disease-free survival in stage 3 resected colon cancer, patients with ctDNA ...

A study finds that celecoxib improves disease-free survival in stage 3 colon cancer patients with positive ctDNA after ...

However, in NSABP C-08, prognostic markers are being evaluated retrospectively to provide more insight into stage II colon cancer. The need for appropriate risk assessment has influenced clinical ...